Takashi M, Sakata T, Nagai T, Kato T, Sahashi M, Koshikawa T, Miyake K
Department of Urology, Nagoya University, School of Medicine, Japan.
Urology. 1990 Jul;36(1):96-8. doi: 10.1016/0090-4295(90)80324-g.
A case of transitional cell carcinoma of the periurethral prostatic ducts received neoadjuvant chemotherapy consisting of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC), which eradicated pelvic lymph node metastasis, followed by cystoprostatectomy. M-VAC therapy may be indicated for metastatic transitional cell carcinoma of the periurethral prostatic ducts.